Immunotherapy: a promising alternative

In brief (20 seconds of reading) : Since 2004, Sophie Lucas, a researcher at the UCLouvain de Duve Institute, has been studying the immune responses that cancer patients can develop against their own tumour She is currently testing a new anti-cancer drug that would strengthen such immune responses This research won the prestigious Academy of Medicine GSK Award, which recognises work in the fields of vaccinology and immunology Sophie Lucas , a researcher at the UCLouvain de Duve Institute , studies the immune responses that cancer patients can develop against their own tumour.
account creation

TO READ THIS ARTICLE, CREATE YOUR ACCOUNT

And extend your reading, free of charge and with no commitment.